• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬口腔颌面部骨肉瘤:综述

Oral and maxillofacial osteosarcoma in dogs: a review.

作者信息

Farcas N, Arzi B, Verstraete F J M

机构信息

William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis, CA, USA.

出版信息

Vet Comp Oncol. 2014 Sep;12(3):169-80. doi: 10.1111/j.1476-5829.2012.00352.x. Epub 2012 Aug 31.

DOI:10.1111/j.1476-5829.2012.00352.x
PMID:22935032
Abstract

Osteosarcoma in dogs is a heterogeneous disease entity with regard to its histologic, clinical and biologic behaviour. Differences in behaviour are associated with tumour location. Oral and maxillofacial osteosarcomas are typically reported as a component of the broader classifications of axial osteosarcoma or osteosarcoma of flat bones to differentiate them from appendicular osteosarcoma. Similar to human oral and maxillofacial osteosarcoma, in dogs, these also appear to have less aggressive behaviour than appendicular osteosarcoma. Ideally, local control is achieved with wide surgical resection that results in tumour-free margins. Failure of local control is the most common contributor to poor prognosis. Chemotherapy and radiation treatment are reported to have variable outcomes. The aim of this article is to review the literature on oral and maxillofacial osteosarcoma in dogs in comparison to appendicular and axial osteosarcoma. Similarities and differences between oral and maxillofacial osteosarcoma in humans are addressed.

摘要

犬骨肉瘤在组织学、临床和生物学行为方面是一种异质性疾病实体。行为差异与肿瘤位置有关。口腔颌面部骨肉瘤通常被报道为轴向骨肉瘤或扁骨骨肉瘤更广泛分类的一个组成部分,以便将它们与四肢骨肉瘤区分开来。与人类口腔颌面部骨肉瘤相似,在犬类中,这些肿瘤的行为似乎也比四肢骨肉瘤的侵袭性小。理想情况下,通过广泛的手术切除实现局部控制,从而获得无肿瘤切缘。局部控制失败是预后不良的最常见原因。据报道,化疗和放疗的效果各不相同。本文的目的是回顾犬口腔颌面部骨肉瘤与四肢和轴向骨肉瘤相比的相关文献。文中还讨论了人类口腔颌面部骨肉瘤之间的异同。

相似文献

1
Oral and maxillofacial osteosarcoma in dogs: a review.犬口腔颌面部骨肉瘤:综述
Vet Comp Oncol. 2014 Sep;12(3):169-80. doi: 10.1111/j.1476-5829.2012.00352.x. Epub 2012 Aug 31.
2
Outcome and prognostic factors for osteosarcoma of the maxilla, mandible, or calvarium in dogs: 183 cases (1986-2012).犬上颌骨、下颌骨或颅骨骨肉瘤的预后及预后因素:183例病例(1986 - 2012年)
J Am Vet Med Assoc. 2014 Oct 15;245(8):930-8. doi: 10.2460/javma.245.8.930.
3
Multilobular osteochondrosarcoma of the canine skull: 16 cases (1978-1988).犬颅骨多叶性骨肉瘤:16例(1978 - 1988年)
J Am Vet Med Assoc. 1989 Dec 15;195(12):1764-9.
4
Sterilization of osteosarcoma in the dog (a case report).犬骨肉瘤的绝育术(病例报告)
Vet Med Small Anim Clin. 1972 Feb;67(2):161-4.
5
Canine sinonasal skeletal neoplasms: chondrosarcomas and osteosarcomas.犬鼻窦骨骼肿瘤:软骨肉瘤和骨肉瘤。
Vet Pathol. 1984 Sep;21(5):475-82. doi: 10.1177/030098588402100504.
6
Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bones.颅外扁平骨和不规则骨犬骨肉瘤生存的临床和组织病理学预后因素评估
Vet Pathol. 2013 Jul;50(4):704-8. doi: 10.1177/0300985812471542. Epub 2012 Dec 26.
7
Osteosarcoma of the maxillofacial bones in Kenyans.肯尼亚人颌面部骨肉瘤
J Craniomaxillofac Surg. 1998 Apr;26(2):98-101. doi: 10.1016/s1010-5182(98)80047-4.
8
What is your diagnosis? Chrondroblastic osteosarcoma.你的诊断是什么?软骨母细胞型骨肉瘤。
J Small Anim Pract. 2003 Nov;44(11):479, 515-6.
9
Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.犬附肢骨肉瘤的生物学、诊断和治疗:与人骨肉瘤的相似性和差异性。
Vet J. 2011 Sep;189(3):268-77. doi: 10.1016/j.tvjl.2010.08.014. Epub 2010 Oct 2.
10
What is your diagnosis? Pulmonary osteoma.
J Am Vet Med Assoc. 2015 Feb 1;246(3):291-3. doi: 10.2460/javma.246.3.291.

引用本文的文献

1
Characterization of the genomic landscape of canine oral osteosarcoma reveals similarities with appendicular osteosarcoma.犬口腔骨肉瘤基因组图谱的特征揭示了其与四肢骨肉瘤的相似性。
PLoS One. 2025 Jun 10;20(6):e0325181. doi: 10.1371/journal.pone.0325181. eCollection 2025.
2
Use of the transposition u-shaped palatal flap and polypropylene mesh to correct oronasal communication after resection of maxillary osteosarcoma in a dog.使用转位U形腭瓣和聚丙烯网片矫正犬上颌骨肉瘤切除术后的口鼻瘘。
Braz J Vet Med. 2024 Nov 18;46:e004824. doi: 10.29374/2527-2179.bjvm004824. eCollection 2024.
3
Subcutaneous leiomyosarcoma in a cynomolgus macaque (Macaca fascicularis).
食蟹猴(Macaca fascicularis)皮下平滑肌肉瘤。
Vet Med Sci. 2024 Jan;10(1):e1321. doi: 10.1002/vms3.1321.
4
Long-term adjuvant metronomic chemotherapy in a dog with recurrent maxillofacial osteosarcoma.一只患有复发性颌面部骨肉瘤的犬的长期辅助节拍化疗。
Vet Med (Praha). 2023 May 25;68(5):225-230. doi: 10.17221/43/2022-VETMED. eCollection 2023 May.
5
Sternohyoideus-sternothyroideus muscle flap to reconstruct oronasal fistulas due to maxillary cancer in four dogs.胸骨舌骨肌-胸骨甲状肌肌瓣重建犬上颌癌所致口鼻瘘。
Vet Surg. 2023 Feb;52(2):299-307. doi: 10.1111/vsu.13923. Epub 2022 Dec 13.
6
Histotripsy Ablation in Preclinical Animal Models of Cancer and Spontaneous Tumors in Veterinary Patients: A Review.癌症临床前动物模型和兽医患者自发性肿瘤的 Histotripsy 消融:综述。
IEEE Trans Ultrason Ferroelectr Freq Control. 2022 Jan;69(1):5-26. doi: 10.1109/TUFFC.2021.3110083. Epub 2021 Dec 31.
7
Locoregional Flap Reconstruction Following Oromaxillofacial Oncologic Surgery in Dogs and Cats: A Review and Decisional Algorithm.犬猫口腔颌面肿瘤手术后的局部皮瓣重建:综述与决策算法
Front Vet Sci. 2021 May 21;8:685036. doi: 10.3389/fvets.2021.685036. eCollection 2021.
8
Micro-RNA 122 and micro-RNA 96 affected human osteosarcoma biological behavior and associated with prognosis of patients with osteosarcoma.微小 RNA-122 和微小 RNA-96 影响人骨肉瘤的生物学行为,并与骨肉瘤患者的预后相关。
Biosci Rep. 2020 Dec 23;40(12). doi: 10.1042/BSR20201529.
9
Extended Subtotal Mandibulectomy for the Treatment of Oral Tumors Invading the Mandibular Canal in Dogs-A Novel Surgical Technique.用于治疗侵犯犬下颌管的口腔肿瘤的扩大性下颌骨次全切除术——一种新型手术技术
Front Vet Sci. 2019 Oct 4;6:339. doi: 10.3389/fvets.2019.00339. eCollection 2019.
10
Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway.骨形态发生蛋白与激活素膜结合抑制剂通过调节转化生长因子-β诱导的上皮-间质转化信号通路抑制MG63和SAOS细胞中的骨癌进展。
Oncol Lett. 2018 Oct;16(4):5113-5121. doi: 10.3892/ol.2018.9268. Epub 2018 Aug 6.